NCT05690776

Brief Summary

The study is a multicenter, retrospective and prospective, non-randomized, noncontrolled, and consecutive series post-market study. The purpose of this study is collect data confirming safety, performance and clinical benefits of the Quattro® X Suture Anchor with BroadBand™ Tape and Instruments when used in rotator cuff repair. The primary endpoint of this study is the assessment of performance by analyzing soft tissue to bone healing in the shoulder (rotator cuff). Healing will be assessed by the investigator using PROMs and clinical outcomes of the patient. The clinical benefit will be assessed by functional outcomes measured using standard and well-established scoring systems (e.g. Constant \& Murley and EQ-5D-5L) at 1 year post-operative. The safety will be assessed by monitoring the incidence and frequency of device- and/or procedure-related adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 19, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 9, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

September 10, 2025

Completed
Last Updated

September 10, 2025

Status Verified

December 1, 2024

Enrollment Period

2.1 years

First QC Date

December 19, 2022

Results QC Date

August 12, 2025

Last Update Submit

September 9, 2025

Conditions

Keywords

Post-Market Clinical Follow-Up StudyMedical DevicePerformanceSafetyClinical Benefits

Outcome Measures

Primary Outcomes (1)

  • Assessment of Performance by Analyzing Soft Tissue to Bone Healing in the Shoulder (Rotator Cuff)

    The investigator will clinically evaluate at 1 year follow-up visit if soft tissue to bone healing has occurred by the absence of device-related revisions and re-tears that were not previously reported. The following question will be asked to the investigator: "Did soft tissue to bone healing occur"? If "yes" is answered, then the soft tissue to bone healing is successful, if "no" is answered, then the soft tissue to bone healing is considered unsuccessful.

    From operation to study completion, 0-1 year

Secondary Outcomes (7)

  • Constant and Murley Score

    From operation to study completion, 0-1 year

  • EQ-5D-5L Score

    From operation to study completion, 0-1 year

  • Assessment of Safety

    From operation to study completion, 0-1 year

  • Subjective Shoulder Value

    From operation to study completion, 0-1 year

  • Pain / Anti-Inflammatory Medication

    1 year after surgery

  • +2 more secondary outcomes

Study Arms (1)

Patients who received the Quattro X BroadBand

No specific interventions will be administered.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects treated with the Quattro® X Suture Anchor with BroadBand™ Tape for rotator cuff repair, according to the IFU and who meet all of the inclusion and none of exclusion criteria.

You may qualify if:

  • Subject treated with the Quattro® X Suture Anchor with BroadBand™ Tape for rotator cuff repair;
  • Older than 18 years and skeletally mature;
  • Willing and able to comply with the study procedures;
  • Subject is capable of understanding the doctor's explanations, following his instructions and is able to participate in the follow-up program;
  • Subject is able to read and understand the ICF and has voluntarily provided written informed consent.

You may not qualify if:

  • Presence of infection;
  • Insufficient or immature bone;
  • Insufficient blood supply or previous infections which may hinder the healing process;
  • Foreign body sensitivity;
  • Subject is vulnerable (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant);
  • The subject is unwilling or unable to give consent or to comply with the follow-up program;
  • Subject meets any contraindications of the appropriate Instruction for Use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ortheo

Saint-Etienne, 42100, France

Location

Centre Clinical

Soyaux, 16800, France

Location

MeSH Terms

Conditions

Rotator Cuff Injuries

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Results Point of Contact

Title
Julie Nicoux
Organization
Zimmer Biomet

Study Officials

  • Hassan Achakri

    Zimmer Biomet

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2022

First Posted

January 19, 2023

Study Start

June 17, 2022

Primary Completion

August 9, 2024

Study Completion

November 15, 2024

Last Updated

September 10, 2025

Results First Posted

September 10, 2025

Record last verified: 2024-12

Locations